Seminar in Boston – Tissue Phenomics™ for Oncology Translational Sciences and Validation of The Immunoscore™
Date: Thursday, June 19, 2014
8:30am – 11:30am
Location: Le Méridien Cambridge-MIT Hotel, Cambridge, MA
* Carlo Bifulco, M.D., Regional Laboratory, Earle A. Chiles Research Institute
* Kristine Burke, Millennium Pharmaceuticals The Takeda Oncology Company
* Elena Geretti, Ph.D., Merrimack Pharmaceuticals
* Thomas Nifong, M.D., Ph.D., Definiens, Inc.
Join us for our upcoming seminar, where we will introduce you to Tissue Phenomics™, a big data approach to oncology translational sciences. Tissue Phenomics™ enables automatic morphological feature classification and contextual spatial analysis of tumor tissue images which can be correlated with patient demographics, gene expression profiles, and clinical outcomes.
This seminar will highlight how leading biopharmaceutical organizations and research institutes are leveraging Definiens’ unique platform in clinical trials, biomarker discovery, and diagnostics development.
The Immunoscore is a trademark of INSERM